bright minds

If the undergoing research ensures fruitful results, then this psychedelic company can create a new future in modern medicine. To be specific, it can create a new pathway of agonism or a treatment regimen, never heard of before with their psychedelic...

This biotechnology company is open for trading in the CSE under the trade name DRUG. Scientific researchers at this company focus on developing novel transformative cures for treating chronic pain, epilepsy, and neuropsychiatry disorders.

Psychedelics drugs are a classification of hallucinogenic drugs that can trigger another level of consciousness, often called psychedelic experiences. Most of them fall under the three families of compounds: phenethylamines, lysergamides, or tryptamines....

Bright Minds Biosciences is a Canadian biotechnology company that deals in the research, and potency of Psilocybin, the active ingredient in magic mushrooms. Experts at this company know that altered states of consciousness (ASC) are one of the best possible...

Addiction to SSRIs is what mental health patients, as well as psychologists, despise. That’s when none of these two parties know how to proceed with the treatment exactly. With numerous nerves just in the central nervous system, many things can go wrong...

Bright Minds Biosciences is a start-up in the field of pharmaceuticals, dealing with neuropsychiatric disorder management through biotechnologically developed drugs. As a biotechnology company , we enforce the ideas and experiences of our experts into...

Trading in psychedelic stocks came to a halt after the ban that the US government imposed. However, the year 2020 saw a major shift in the research industry that studies probable treatments for neurological and mental health disorders. The same year,...

Bright Minds a biotechnology company dedicated to developing next-generation therapeutics to improve the lives of patients with severe and life-altering brain diseases. Bright Minds’ broad portfolio of new chemical entities (NCEs) are positioned to treat...

Investors are funding researches and studies carried out by biotechnology companies such as Bright Minds Biosciences . This positive shift in the psychedelic space has occurred due to people becoming more aware of these compounds' possible benefits.

The year 2021 marked the beginning of psychedelic researches in public, as many biotechnology companies emerged as active players in this industry. Research organizations, such as Bright Minds Biosciences, a biotechnology company, raised above $2000 million...